首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1873994

切片設備市場

Biopsy Devices Market

出版日期: 2025年11月01日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

預計活體組織切片設備市場將從 2024 年的 30 億美元成長到 2031 年的 45.9 億美元，2031 年至 2031 年的年複合成長率(CAGR) 為 6.20%。推動活體組織切片設備市場成長的關鍵趨勢包括癌症發病率上升、活體組織切片手術增加以及活體組織切片技術的進步。

切片設備市場分析

市場成長的促進因素包括：人們對微創手術的偏好日益成長、癌症診斷率的激增以及政府旨在提高癌症檢測率的舉措。活體組織切片是多種癌症（包括乳腺癌、皮膚癌和前列腺癌）的關鍵診斷方法。泛美衛生組織的數據顯示，未來20年全球癌症負擔預計將增加約60%，到2040年預計將新增3,000萬例癌症病例，尤其是中低收入國家。因此，癌症發生率的上升和活體組織切片技術的進步預計將在預測期內推動市場成長。

切片設備市場概覽

北美地區在活體組織切片器械市場佔據領先地位，其中美國市場佔有率最大，其次是加拿大。對微創活體組織切片手術的需求顯著推動了北美市場的成長。根據美國整形外科醫師協會統計，2022年美國共進行了約23,672,269例美容性微創手術，這帶動了對活體組織切片器械的需求，進而促進了市場成長。

戰略洞察

活體組織切片設備市場促進因素與機遇

癌症發生率上升推高了對活體組織切片設備的需求

全球癌症病例的激增是推動活體組織切片設備市場發展的主要因素。準確及時的癌症診斷對於有效治療至關重要，因此活體組織切片成為一種重要的診斷工具。世界衛生組織報告稱，2022年全球新增癌症病例約2,000萬例，癌症相關死亡病例約970萬例，五分之一的人一生中可能會罹患癌症。因此，活體組織切片設備對於識別惡性組織和輔助醫生製定治療方案至關重要。

活體組織檢查設備的科技創新帶來市場機遇

醫療技術的進步和快速創新是市場成長的重要推動因素。多年來，這些發展顯著提高了活體組織切片手術的有效性、速度和安全性。例如，真空輔助活體組織切片設備能夠更快、更舒適地提取組織樣本。此外，將CT掃描、超音波或MRI等即時影像技術與活體組織切片設備結合，可實現更精準的標靶定位，減少併發症，並提高診斷準確性。這些技術進步正在推動醫療專業人員對活體組織切片設備的接受度不斷提高，從而進一步促進了活體組織切片設備市場的發展。

活體組織切片設備市場報告細分分析

活體組織切片設備市場分析按產品、技術和應用進行細分。

該產品類別包括針刺活體組織切片、定位導絲、手術托盤和其他產品，其中針刺活體組織切片設備因其高精度和最小的損傷，在 2023 年佔據了最大的市場佔有率。
從技術角度來看，市場分為 CT 掃描、超音波引導活體組織切片、立體定位引導活體組織切片、MRI 引導活體組織切片和其他，其中超音波引導活體組織切片在 2023 年佔據最大佔有率，而 CT 掃描在預測期內複合年成長率最高。
從應用領域來看，市場分為肺活體組織切片、腎臟活體組織切片、肝臟活體組織切片、乳房活體組織切片和其他，其中乳房活體組織切片領域在 2023 年佔據了市場佔有率的領先地位。

按地域分類的活體組織切片設備市場佔有率分析

活體組織切片設備市場報告涵蓋五個主要地區：北美、亞太地區、歐洲、中東和非洲以及南美/中南美洲。

北美在活體組織切片設備市場佔據主導地位，這主要得益於活體組織切片設備在各種應用領域的日益普及、癌症病例數量的不斷成長、主要製造商的存在，以及製藥和生物技術公司在北美醫療器材領域的投資。根據泛美衛生組織統計，癌症是美洲第二大疾病和死亡原因，僅次於心血管疾病。 2020年，美洲新增癌症病例約400萬例，癌症死亡病例約140萬例。不斷成長的癌症確診患者群體將增加對活體組織切片設備的需求，從而推動市場成長。

活體組織切片設備市場報告範圍

活體組織切片設備市場最新發展

活體組織切片器械市場評估是基於從一手和二手研究中獲得的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。活體組織切片器械市場的最新發展包括：

TransMed7公司宣布，其商業化生產版Heron XPS設備已完成首次人體臨床試驗。該設備是新型真空輔助單次插入/多次採集軟組織活體組織切片設備系列中的一款。（資料來源：Transmed7，新聞稿/公司網站/簡報，2022年8月）
波士頓科學公司（Boston Scientific Corporation）的WATCHMAN FLX Pro左心耳封堵器獲得FDA批准，該裝置旨在提高非瓣膜性房顫患者（需要口服抗凝血治療替代方案）的手術操作性和安全性。（資料來源：波士頓科學公司，新聞稿/公司網站/簡報，2023年9月）
丹納赫公司旗下子公司Mammotome推出了Mammotome Revolve™ EX雙真空輔助乳房切片系統，這是首款專為切除良性乳房病變而設計的設備，提供了一種微創解決方案，可最大限度地降低風險和疤痕。（資料來源：丹納赫公司，新聞稿/公司網站/簡報，2022年8月）

活體組織切片設備市場報告涵蓋範圍和成果

《活體組織切片設備市場規模及預測（2021-2031）》報告對市場進行了全面分析，涵蓋以下領域：

全球、區域和國家層面所有主要細分市場的市場規模和預測。
市場動態，包括促進因素、限制因素和主要機會。
未來趨勢分析。
詳細的PEST/波特五力模型和SWOT分析。
全球及區域市場分析，涵蓋關鍵趨勢、主要參與者、法規及最新發展。
產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展。
深入的公司概況。

The Biopsy Devices Market is anticipated to grow from US$ 3.00 billion in 2024 to US$ 4.59 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.20% during the period from 2031 to 2031. Key trends driving the Biopsy Devices market include the rising incidence of cancer, an increase in biopsy procedures, and advancements in biopsy technology.

Biopsy Devices Market Analysis

The market growth is being propelled by factors such as a growing preference for minimally invasive procedures, a surge in cancer diagnoses, and government initiatives aimed at improving cancer detection. Biopsy is a crucial diagnostic method for various cancers, including breast, skin, and prostate cancers. Data from the Pan American Health Organization indicates that the global cancer burden is expected to rise by about 60% over the next 20 years, with an estimated 30 million new cancer cases projected by 2040, particularly in low- and middle-income nations. Consequently, the increasing cancer incidence and advancements in biopsy technology are expected to drive market growth during the forecast period.

Biopsy Devices Market Overview

North America leads the Biopsy Devices market, with the United States holding the largest share, followed by Canada. The demand for minimally invasive biopsy procedures significantly contributes to the growth of the North American market. According to the American Society of Plastic Surgeons, approximately 23,672,269 cosmetic minimally invasive procedures were performed in the U.S. in 2022, which drives the need for biopsy devices and subsequently boosts market growth.

Strategic Insights

Biopsy Devices Market Drivers and Opportunities

Increasing Cancer Prevalence Boosts Demand for Biopsy Devices

The global rise in cancer cases is a major factor driving the biopsy device market. Accurate and early cancer diagnosis is essential for effective treatment, making biopsy a vital diagnostic tool. The World Health Organization reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths in 2022, with 1 in 5 individuals likely to develop cancer in their lifetime. Thus, biopsy devices are crucial for identifying malignant tissues and assisting physicians in formulating treatment plans.

Technological Innovations in Biopsy Devices Present Market Opportunities

Advancements in medical technology and rapid innovations are significant contributors to market growth. These developments have enhanced the efficacy, speed, and safety of biopsy procedures over the years. For example, vacuum-assisted biopsy devices facilitate quicker and more comfortable tissue sample extraction. Moreover, integrating real-time imaging techniques such as CT scans, ultrasounds, or MRIs with biopsy devices allows for more precise targeting, fewer complications, and improved diagnostic accuracy. Such technological progress is leading to increased adoption rates among healthcare professionals, further driving the biopsy device market.

Biopsy Devices Market Report Segmentation Analysis

The Biopsy Devices Market analysis is segmented by product, technology, and application.

The product segment includes Needle-Based Biopsy, Localization Wires, Procedure Trays, and Others, with needle-based biopsy devices capturing the largest market share in 2023 due to their high accuracy and minimal injury.
In terms of technology, the market is divided into CT Scan, Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, and Others, where the Ultrasound-Guided Biopsy segment held the largest share in 2023, while the CT Scan segment exhibited the fastest CAGR during the forecast period.
For applications, the market is categorized into Lung Biopsy, Kidney Biopsy, Liver Biopsy, Breast Biopsy, and Others, with the Breast Biopsy segment leading the market share in 2023.

Biopsy Devices Market Share Analysis by Geography

The Biopsy Devices Market report covers five main regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America dominates the Biopsy Devices Market, driven by the increasing adoption of biopsy devices across various applications, a rising number of cancer cases, the presence of major manufacturers, and investments from pharmaceutical and biotech companies in medical devices within North America. According to the Pan American Health Organization, cancer is the second leading cause of morbidity and mortality in the Americas, following cardiovascular diseases, with an estimated 4 million new cancer diagnoses and 1.4 million cancer deaths in 2020. This growing diagnosed cancer population will increase the demand for biopsy devices, thereby fueling market growth.

Biopsy Devices Market Report Scope

Recent Developments in the Biopsy Devices Market

The Biopsy Devices Market is assessed through qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Recent developments in the Biopsy Devices market include:

TransMed7, LLC announced a "First in Human" clinical case for the commercial production version of the Heron XPS device, part of a new family of vacuum-assisted, single insertion/multiple collection soft tissue biopsy devices. (Source: Transmed7, Press Release/Company Website/Newsletter, August 2022)
Boston Scientific Corporation received FDA approval for the WATCHMAN FLX Pro Left Atrial Appendage Closure Device, designed to enhance procedural performance and safety for patients with non-valvular atrial fibrillation needing alternatives to oral anticoagulation therapy. (Source: Boston Scientific Corporation, Press Release/Company Website/Newsletter, September 2023)
Mammotome, a subsidiary of Danaher Corporation, launched the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System, the first device specifically designed for the excision of benign breast lesions, offering a minimally invasive solution that minimizes risks and scarring. (Source: Danaher Corporation, Press Release/Company Website/Newsletter, August 2022)

Biopsy Devices Market Report Coverage and Deliverables

The "Biopsy Devices Market Size and Forecast (2021-2031)" report provides a comprehensive analysis of the market, covering the following areas:

Market size and forecast at global, regional, and country levels for all key market segments.
Market dynamics including drivers, restraints, and key opportunities.
Future trends analysis.
Detailed PEST/Porter's Five Forces and SWOT analysis.
Global and regional market analysis covering key trends, major players, regulations, and recent developments.
Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
In-depth company profiles.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Biopsy Devices Market and By Product
- 1.3.2 Biopsy Devices Market and By Technology
- 1.3.3 Biopsy Devices Market and By Application
- 1.3.4 Biopsy Devices Market and By Geography

2. Biopsy Devices Market and Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Biopsy Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America and PEST Analysis
- 4.2.2 Europe and PEST Analysis
- 4.2.3 Asia-Pacific and PEST Analysis
- 4.2.4 Middle East and Africa and PEST Analysis
- 4.2.5 South and Central America and PEST Analysis
4.3 Expert Opinions
4.4 Reimbursement Scenario

5. Global Biopsy Devices Market and Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Cancer Rates
- 5.1.2 Government Support and Initiatives
5.2 Market Restraints
- 5.2.1 Limitations Associated with Biopsy
5.3 Market Opportunities
- 5.3.1 Increasing Awareness Regarding Early Disease Detection
5.4 Future Trends
- 5.4.1 Consistent Improvement in Product Designs
5.5 Impact Analysis of Drivers and Restraints

6. Biopsy Devices Market and Global Analysis

6.1 Global Biopsy Devices Market - Overview
6.2 Global Biopsy Devices Market and Revenue Forecasts and Analysis
6.3 Global Biopsy Devices Market, By Geography - Forecast And Analysis
6.4 Market Positioning of Key Players

7. Biopsy Devices Market Analysisand by Product

7.1 Overview
7.2 Biopsy Devices Market, By Product, 2024 and 2031 (%)
- 7.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Product (US$ Million)
- 7.2.2 Needle-Based Biopsy Market Revenue and Forecasts to 2031, By Type (US$ Million)
7.3 Needle-Based Biopsy
- 7.3.1 Overview
- 7.3.2 Needle-Based Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
- 7.3.3 Core Biopsy Devices
  - 7.3.3.1 Overview
  - 7.3.3.2 Core Biopsy Devices Market Revenue and Forecasts to 2031 (US$ Million)
- 7.3.4 Aspiration Biopsy Needles
  - 7.3.4.1 Overview
  - 7.3.4.2 Aspiration Biopsy Needles Market Revenue and Forecasts to 2031 (US$ Million)
- 7.3.5 Vacuum Assisted Biopsy (VAB) Devices
  - 7.3.5.1 Overview
  - 7.3.5.2 Vacuum Assisted Biopsy (VAB) Devices Market Revenue and Forecasts to 2031 (US$ Million)
7.4 Localization Wires
- 7.4.1 Overview
- 7.4.2 Localization Wires Market Revenue and Forecasts to 2031 (US$ Million)
7.5 Procedure Trays
- 7.5.1 Overview
- 7.5.2 Procedure Trays Market Revenue and Forecasts to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

8. Biopsy Devices Market Analysisand by Technology

8.1 Overview
8.2 Biopsy Devices Market, By Technology, 2024 and 2031 (%)
- 8.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Technology (US$ Million)
8.3 CT Scan
- 8.3.1 Overview
- 8.3.2 CT Scan Market Revenue and Forecasts to 2031 (US$ Million)
8.4 Ultrasound Guided Biopsy
- 8.4.1 Overview
- 8.4.2 Ultrasound Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
8.5 Stereotactic Guided Biopsy
- 8.5.1 Overview
- 8.5.2 Stereotactic Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
8.6 MRI Guided Biopsy
- 8.6.1 Overview
- 8.6.2 MRI Guided Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

9. Biopsy Devices Market Analysisand by Application

9.1 Overview
9.2 Biopsy Devices Market, By Application, 2024 and 2031 (% Share)
- 9.2.1 Biopsy Devices Market Revenue and Forecasts to 2031, By Application (US$ Million)
9.3 Lung Biopsy
- 9.3.1 Overview
- 9.3.2 Lung Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
9.4 Kidney Biopsy
- 9.4.1 Overview
- 9.4.2 Kidney Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
9.5 Liver Biopsy
- 9.5.1 Overview
- 9.5.2 Liver Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
9.6 Breast Biopsy
- 9.6.1 Overview
- 9.6.2 Breast Biopsy Market Revenue and Forecasts to 2031 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others Market Revenue and Forecasts to 2031 (US$ Million)

10. Biopsy Devices Market and Geographic Analysis

10.1 North America: Biopsy devices Market
- 10.1.1 Overview
- 10.1.2 North America: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
- 10.1.3 North America: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
  - 10.1.3.1 North America: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
- 10.1.4 North America: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
- 10.1.5 North America: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.1.6 North America: Biopsy devices Market, by Country, 2024 and 2031 (%)
- 10.1.7 US: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.7.1 US: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.7.2 US: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.1.7.2.1 US: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.1.7.3 US: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.1.7.4 US: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.1.8 Canada: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.8.1 Canada: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.8.2 Canada: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.1.8.2.1 Canada: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.1.8.3 Canada: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.1.8.4 Canada: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.1.9 Mexico: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.9.1 Mexico: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.1.9.2 Mexico: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.1.9.2.1 Mexico: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.1.9.3 Mexico: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.1.9.4 Mexico: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
10.2 Europe: Biopsy devices Market
- 10.2.1 Overview
- 10.2.2 Europe: Biopsy devices Market - Revenue and Forecast to 2031 (USD Million)
- 10.2.3 Europe: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
  - 10.2.3.1 Europe: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
- 10.2.4 Europe: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
- 10.2.5 Europe: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.6 Europe: Biopsy devices Market, by Country, 2024 and 2031 (%)
- 10.2.7 Germany: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.1 Germany: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.7.2 Germany: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.7.2.1 Germany: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.7.3 Germany: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.7.4 Germany: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.8 UK: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.1 UK: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.8.2 UK: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.8.2.1 UK: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.8.3 UK: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.8.4 UK: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.9 France: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.1 France: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.9.2 France: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.9.2.1 France: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.9.3 France: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.9.4 France: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.10 Spain: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.1 Spain: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.10.2 Spain: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.10.2.1 Spain: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.10.3 Spain: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.10.4 Spain: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.11 Italy: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.1 Italy: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.11.2 Italy: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.11.2.1 Italy: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.11.3 Italy: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.11.4 Italy: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.12 Sweden: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.12.1 Sweden: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.12.2 Sweden: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.12.2.1 Sweden: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.12.3 Sweden: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.12.4 Sweden: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.13 Denmark: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.13.1 Denmark: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.13.2 Denmark: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.13.2.1 Denmark: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.13.3 Denmark: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.13.4 Denmark: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.2.14 Norway: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.14.1 Norway: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.2.14.2 Norway: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.2.14.2.1 Norway: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.2.14.3 Norway: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.2.14.4 Norway: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
10.3 Asia-Pacific: Biopsy Devices Market
- 10.3.1 Overview
- 10.3.2 Asia-Pacific: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
- 10.3.6 Asia-Pacific: Biopsy Devices Market, by Country, 2024 and 2031 (%)
- 10.3.7 China: Biopsy Devices Market
  - 10.3.7.1 China: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
  - 10.3.7.2 China: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.3.7.2.1 China: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.3.7.3 China: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.3.7.4 China: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.3.8 Japan: Biopsy Devices Market
  - 10.3.8.1 Japan: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
  - 10.3.8.2 Japan: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.3.8.2.1 Japan: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.3.8.3 Japan: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.3.8.4 Japan: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.3.9 India: Biopsy Devices Market
  - 10.3.9.1 India: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
  - 10.3.9.2 India: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.3.9.2.1 India: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.3.9.3 India: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.3.9.4 India: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.3.10 South Korea: Biopsy Devices Market
  - 10.3.10.1 South Korea: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
  - 10.3.10.2 South Korea: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.3.10.2.1 South Korea: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.3.10.3 South Korea: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.3.10.4 South Korea: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.3.11 Australia: Biopsy Devices Market
  - 10.3.11.1 Australia: Biopsy Devices Market and Revenue and Forecast to 2031 (USD Millions)
  - 10.3.11.2 Australia: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.3.11.2.1 Australia: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.3.11.3 Australia: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.3.11.4 Australia: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
10.4 Middle East and Africa: Biopsy Devices Market
- 10.4.1 Overview
- 10.4.2 Middle East and Africa: Biopsy Devices Market- Revenue and Forecast to 2031 (USD Million)
- 10.4.6 Middle East and Africa: Biopsy Devices Market, by Country, 2024 and 2031 (%)
- 10.4.7 Saudi Arabia: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.1 Saudi Arabia: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.7.2 Saudi Arabia: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.4.7.2.1 Saudi Arabia: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.4.7.3 Saudi Arabia: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.4.7.4 Saudi Arabia: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.4.8 UAE: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.1 UAE: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.8.2 UAE: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.4.8.2.1 UAE: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.4.8.3 UAE: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.4.8.4 UAE: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.4.9 South Africa: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.1 South Africa: Biopsy Devices Marketand Revenue and Forecast to 2031 (USD Million)
  - 10.4.9.2 South Africa: Biopsy Devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.4.9.2.1 South Africa: Needle-Based Biopsy Devices Market, by Type, 2024 and 2031 (USD Million)
  - 10.4.9.3 South Africa: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.4.9.4 South Africa: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
10.5 South and Central America: Biopsy devices Market
- 10.5.1 Overview
- 10.5.2 South and Central America: Biopsy devices Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 South and Central America: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
  - 10.5.3.1 South and Central America: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
- 10.5.4 South and Central America: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
- 10.5.5 South and Central America: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.5.6 South and Central America: Biopsy devices Market, by Country, 2024 and 2031 (%)
- 10.5.7 Brazil: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.1 Brazil: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.5.7.2 Brazil: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.5.7.2.1 Brazil: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.5.7.3 Brazil: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.5.7.4 Brazil: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)
- 10.5.8 Argentina: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.1 Argentina: Biopsy devices Market and Revenue and Forecast to 2031 (USD Million)
  - 10.5.8.2 Argentina: Biopsy devices Market, by Product, 2024 and 2031 (USD Million)
    - 10.5.8.2.1 Argentina: Needle-Based Biopsy Devices, Market, by Type, 2024 and 2031 (USD Million)
  - 10.5.8.3 Argentina: Biopsy Devices, Market, by Technology, 2024 and 2031 (USD Million)
  - 10.5.8.4 Argentina: Biopsy Devices Market, by Application, 2024 and 2031 (USD Million)

11. Impact of COVID-19 Pandemic on Global Biopsy Devices Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Biopsy Devices Market and Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 B. Braun Melsungen AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Cardinal Health Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Cook Medical LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Danaher
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Fujifilm Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Hologic, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Medtronic
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Argon Medical Devices
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments